@article{8f8baea8f34d4f77b38a417660cf48c1,
title = "Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study",
abstract = "AtLaS was a single-arm pilot study that demonstrated promising efficacy and safety of treatment simplification to a dual regimen with atazanavir/ritonavir + lamivudine in virologically suppressed HIV-positive patients. Here, we report data from the 144 week follow-up.",
keywords = "antiviral, combined antiretroviral therapy, dual therapy, antiviral, combined antiretroviral therapy, dual therapy",
author = "Annalisa Mondi and Massimiliano Fabbiani and Nicoletta Ciccarelli and Manuela Colafigli and Alessandro D'Avino and Alberto Borghetti and Roberta Gagliardini and Roberto Cauda and {De Luca}, A. and {De Luca}, Andrea and {Di Giambenedetto}, Simona",
year = "2015",
doi = "10.1093/jac/dkv037",
language = "English",
volume = "70",
pages = "1843--1849",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
}